Nifty

:

11513.90

Sensex

:

39052.06

49.90 (0.44%)
453.07 (1.17%)

Login

Nifty
Sensex

:
:

11513.90
39052.06

49.90 (0.44%)
453.07 (1.17%)

Triochem Products Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 512101 | NSE: Not Listed

Watchlist

NSE BSE

Not traded in the last 30 days

Open
High
Low
Previous Close

N/A
N/A
N/A
N/A

Volume
Traded Value (lacs)
52 Week High
52 Week Low

N/A
N/A
N/A
N/A

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

0.43
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5.97
N/A
0.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

34.66
-16.64
-11.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
5.71
10.53

PAT CAGR (%)

10 Years
5 Years
3 Years

-
11.99
7.84

P:E (Median)

8 Years
5 Years
3 Years

0.28
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.10
0.09
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

4.43
8.08
-

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 0.53 6.71 -92.10% 3.40 12.50 -72.80% 1.95 6.50 -70.00% 0.30 3.47 -91.35%
Expenses 0.82 5.79 -85.84% 2.63 10.50 -74.95% 1.94 5.99 -67.61% 0.36 3.46 -89.60%
EBITDA -0.30 0.92 - 0.77 2.00 -61.50% 0.01 0.52 -98.08% -0.06 0.01 -
EBIDTM -56.46% 13.66% 22.77% 16.03% 0.62% 7.93% -19.06% 0.29%
Other Income 0.00 0.01 -100.00% 0.02 0.19 -89.47% 0.01 0.03 -66.67% 0.02 0.04 -50.00%
Interest 0.05 0.12 -58.33% 0.08 0.04 100.00% 0.12 0.16 -25.00% 0.14 0.12 16.67%
Depreciation 0.04 0.05 -20.00% 0.05 0.06 -16.67% 0.05 0.06 -16.67% 0.05 0.06 -16.67%
PBT -0.39 0.76 - 0.66 2.09 -68.42% -0.14 0.32 - -0.23 -0.13 -
Tax -0.11 0.19 - 0.24 0.61 -60.66% -0.05 0.09 - -0.08 -0.04 -
PAT -0.28 0.57 - 0.42 1.49 -71.81% -0.09 0.23 - -0.15 -0.09 -
PATM -53.42% 8.42% 12.44% 11.89% -4.72% 3.51% -51.17% -2.60%
EPS -11.47 23.06 - 17.27 60.65 -71.53% -3.76 9.31 - -6.24 -3.67 -

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 6.18 12.35 34.99 18.06 23.11 30.68 33.74 30.80 12.36 5.14 0.63 Net Sales Growth -78.82% -64.70% 93.74% -21.85% -24.67% -9.07% 9.55% 149.19% 140.47% 715.87% Cost Of Goods Sold 3.57 8.32 28.62 15.05 20.51 27.54 30.87 26.60 8.47 3.88 0.44 Gross Profit 2.61 4.03 6.36 3.01 2.61 3.13 2.88 4.21 3.89 1.27 0.19 GP Margin 42.15% 32.63% 18.18% 16.67% 11.29% 10.20% 8.54% 13.67% 31.47% 24.71% 30.16% Total Expenditure 5.75 10.70 31.19 17.06 22.15 29.43 32.38 28.14 9.94 4.45 1.06 Power & Fuel Cost - 0.61 0.75 0.53 0.41 0.60 0.51 0.47 0.35 0.15 0.01 % Of Sales - 4.94% 2.14% 2.93% 1.77% 1.96% 1.51% 1.53% 2.83% 2.92% 1.59% Employee Cost - 0.72 0.73 0.67 0.50 0.55 0.55 0.51 0.28 0.10 0.06 % Of Sales - 5.83% 2.09% 3.71% 2.16% 1.79% 1.63% 1.66% 2.27% 1.95% 9.52% Manufacturing Exp. - 0.65 0.59 0.45 0.33 0.29 0.28 0.38 0.64 0.26 0.37 % Of Sales - 5.26% 1.69% 2.49% 1.43% 0.95% 0.83% 1.23% 5.18% 5.06% 58.73% General & Admin Exp. - 0.20 0.26 0.25 0.24 0.21 0.13 0.10 0.06 0.04 0.05 % Of Sales - 1.62% 0.74% 1.38% 1.04% 0.68% 0.39% 0.32% 0.49% 0.78% 7.94% Selling & Distn. Exp. - 0.02 0.01 0.01 0.02 0.04 0.02 0.07 0.01 0.00 0.01 % Of Sales - 0.16% 0.03% 0.06% 0.09% 0.13% 0.06% 0.23% 0.08% 0% 1.59% Miscellaneous Exp. - 0.19 0.23 0.10 0.15 0.20 0.03 0.03 0.13 0.04 0.01 % Of Sales - 1.54% 0.66% 0.55% 0.65% 0.65% 0.09% 0.10% 1.05% 0.78% 19.05% EBITDA 0.42 1.65 3.80 1.00 0.96 1.25 1.36 2.66 2.42 0.69 -0.43 EBITDA Margin 6.80% 13.36% 10.86% 5.54% 4.15% 4.07% 4.03% 8.64% 19.58% 13.42% -68.25% Other Income 0.05 0.06 0.41 0.17 0.02 0.08 0.21 0.27 0.08 0.16 0.21 Interest 0.39 0.46 0.40 0.07 0.20 0.45 0.47 1.39 0.01 0.01 0.01 Depreciation 0.19 0.21 0.25 0.28 0.27 0.32 0.31 0.33 0.16 0.03 0.02 PBT -0.10 1.04 3.57 0.82 0.52 0.55 0.79 1.21 2.33 0.81 -0.25 Tax 0.00 0.30 1.01 0.23 0.17 0.13 0.26 0.41 0.76 0.19 0.00 Tax Rate 0.00% 28.85% 28.29% 28.05% 32.69% 23.64% 32.91% 33.88% 32.62% 22.89% 0.00% PAT -0.10 0.74 2.56 0.59 0.34 0.42 0.53 0.80 1.57 0.64 -0.25 PAT before Minority Interest -0.10 0.74 2.56 0.59 0.34 0.42 0.53 0.80 1.57 0.64 -0.25 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.62% 5.99% 7.32% 3.27% 1.47% 1.37% 1.57% 2.60% 12.70% 12.45% -39.68% PAT Growth -104.55% -71.09% 333.90% 73.53% -19.05% -20.75% -33.75% -49.04% 145.31% - Unadjusted EPS -4.20 30.33 104.29 23.93 13.94 16.98 21.46 32.73 64.22 26.11 -10.24

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 8.78 8.03 5.48 4.89 4.55 4.14 3.61 2.81 1.24 0.60 Share Capital 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 Total Reserves 8.53 7.79 5.24 4.65 4.31 3.89 3.37 2.56 0.99 0.35 Non-Current Liabilities 0.12 0.13 0.16 0.22 0.23 0.83 0.33 0.83 0.69 0.38 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 6.26 3.64 4.64 1.91 3.70 5.96 17.11 6.97 1.30 0.72 Trade Payables 0.34 0.72 1.66 1.75 0.10 0.86 0.14 0.46 0.03 0.11 Other Current Liabilities 0.03 0.01 0.01 0.01 0.07 0.02 0.80 0.19 0.17 0.55 Short Term Borrowings 5.79 2.28 2.86 0.00 3.50 4.78 16.16 6.25 0.95 0.00 Short Term Provisions 0.09 0.63 0.11 0.15 0.02 0.30 0.01 0.07 0.15 0.06 Total Liabilities 15.16 11.80 10.28 7.02 8.48 10.93 21.05 10.61 3.23 1.70 Net Block 1.14 1.33 1.64 1.85 1.72 2.04 2.35 2.48 1.18 0.25 Gross Block 1.85 1.84 5.11 5.05 4.65 4.65 4.65 4.45 2.99 2.03 Accumulated Depreciation 0.72 0.51 3.48 3.20 2.93 2.61 2.30 1.97 1.80 1.77 Non Current Assets 1.31 1.85 2.11 5.98 2.47 2.47 2.69 2.69 1.62 1.13 Capital Work in Progress 0.00 0.00 0.00 0.04 0.37 0.22 0.11 0.00 0.22 0.41 Non Current Investment 0.09 0.09 0.00 3.68 0.12 0.12 0.12 0.12 0.12 0.47 Long Term Loans & Adv. 0.08 0.43 0.47 0.39 0.26 0.10 0.11 0.09 0.10 0.00 Other Non Current Assets 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Current Assets 13.84 9.95 8.17 1.05 6.01 8.46 18.36 7.92 1.61 0.57 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.57 8.23 2.20 0.33 4.22 4.91 11.23 7.59 0.47 0.00 Sundry Debtors 3.33 0.00 2.45 0.00 0.17 2.34 6.19 0.00 0.00 0.00 Cash & Bank 0.25 0.92 0.40 0.37 0.96 0.41 0.13 0.06 0.70 0.13 Other Current Assets 0.69 0.07 0.05 0.04 0.67 0.79 0.82 0.27 0.44 0.43 Short Term Loans & Adv. 0.67 0.73 3.07 0.30 0.39 0.71 0.72 0.16 0.32 0.42 Net Current Assets 7.59 6.31 3.53 -0.87 2.32 2.50 1.25 0.95 0.31 -0.15 Total Assets 15.15 11.80 10.28 7.03 8.48 10.93 21.05 10.61 3.23 1.70

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity -3.75 1.45 -6.48 6.79 2.34 12.20 -8.08 -4.74 0.32 -0.31 PBT 1.04 3.57 0.83 0.53 0.55 0.81 1.21 2.33 0.83 -0.25 Adjustment 0.64 0.57 0.30 0.43 0.73 0.75 1.68 0.16 0.02 0.06 Changes in Working Capital -4.57 -2.02 -7.41 5.86 1.71 10.66 -10.53 -6.57 -0.51 -0.10 Cash after chg. in Working capital -2.89 2.12 -6.28 6.81 2.98 12.22 -7.64 -4.08 0.33 -0.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.86 -0.67 -0.20 -0.03 -0.65 -0.02 -0.44 -0.67 -0.02 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.02 -0.01 3.71 -3.70 -0.10 -0.10 -0.41 -1.20 -0.40 0.03 Net Fixed Assets -0.01 3.27 -0.02 -0.07 -0.15 -0.11 -0.31 -1.24 -0.77 -0.41 Net Investments 0.00 -0.09 3.68 -3.56 0.00 0.00 0.00 0.00 0.35 0.51 Others 0.03 -3.19 0.05 -0.07 0.05 0.01 -0.10 0.04 0.02 -0.07 Cash from Financing Activity 3.06 -0.92 2.80 -3.68 -1.69 -11.83 8.55 5.30 0.65 0.32 Net Cash Inflow / Outflow -0.67 0.52 0.03 -0.59 0.56 0.28 0.07 -0.65 0.57 0.05 Opening Cash & Equivalents 0.92 0.40 0.37 0.96 0.41 0.13 0.06 0.70 0.13 0.08 Closing Cash & Equivalent 0.25 0.92 0.40 0.37 0.96 0.41 0.13 0.06 0.70 0.13

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 358.19 327.86 223.69 199.76 185.82 168.86 147.40 114.67 50.45 24.34 ROA 5.51% 23.15% 6.78% 4.41% 4.29% 3.29% 5.06% 22.74% 26.01% -15.14% ROE 8.84% 37.82% 11.30% 7.23% 9.57% 13.57% 24.98% 77.79% 69.82% -34.58% ROCE 12.05% 42.55% 13.48% 11.10% 11.82% 8.80% 18.02% 41.56% 54.49% -28.11% Fixed Asset Turnover 6.68 10.21 3.62 4.96 7.09 7.61 7.11 3.47 2.05 0.31 Receivable days 98.38 0.00 48.54 0.00 13.89 43.98 34.92 0.06 0.00 0.00 Inventory Days 262.93 53.53 25.10 34.53 50.59 83.29 106.16 114.05 16.59 0.09 Payable days 13.73 14.12 33.71 18.02 5.66 6.66 3.54 6.36 5.16 24.79 Cash Conversion Cycle 347.59 39.41 39.93 16.52 58.82 120.61 137.55 107.74 11.42 -24.69 Total Debt/Equity 0.66 0.28 0.52 0.00 0.77 1.15 4.47 2.22 0.77 0.50 Interest Cover 3.26 9.98 12.65 3.55 2.21 2.66 1.87 296.05 84.38 -29.92

Top Investors:

ambernath plasto packaging private

g amphray pharmaceuticals private l

triochem laboratories private limit

ramesh rajaram patil

snehprabha agarwal

savitri nareshchandra jain

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback